Cc1cc(N(C)C(=O)c2ccc3c(c2)S(=O)(=O)c2cc(Cl)ccc2C3=O)c(C(F)(F)F)o1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?